Abstract
Schistosomiasis is a major neglected parasitic disease that affects more than 240 million people worldwide caused by Platyhelminthes of the genus Schistosoma. The treatment of schistosomiasis relies on the long-term application of a single safe drug, praziquantel (PZQ). Unfortunately, PZQ is very effective on adult parasites and poorly on larval stage and immature juvenile worms; this can partially explain the re-infection in endemic areas where patients are likely to host parasites at different developmental stages concurrently. Moreover, the risk of development of drug resistance because of the widespread use of a single drug in a large population is nowadays a serious threat. Hence, research aimed at identifying novel drugs to be used alone or in combination with PZQ is needed. Schistosomes display morphologically distinct stages during their life cycle and epigenetic mechanisms are known to play important roles in parasite growth, survival, and development. Histone deacetylase (HDAC) enzymes, particularly HDAC8, are considered valuable for therapeutic intervention for the treatment of schistosomiasis. Herein, we report the phenotypic screening on both larvae and adult Schistosoma mansoni stages of structurally different HDAC inhibitors selected from the in-house Siena library. All molecules have previously shown inhibition profiles on human HDAC6 and/or HDAC8 enzymes. Among them we identified a quinolone-based HDAC inhibitor, NF2839, that impacts larval and adult parasites as well as egg viability and maturation in vitro. Importantly, this quinolone-based compound also increases histone and tubulin acetylation in S. mansoni parasites, thus representing a leading candidate for the development of new generation anti-Schistosoma chemotherapeutics.
Funder
Ministero dell'Università e della Ricerca
Consiglio Nazionale delle Ricerche
Lazio Innova
Publisher
Public Library of Science (PLoS)
Reference33 articles.
1. Schistosomiasis.;DP McManus;Nat Rev Dis Primers,2018
2. Vaccines for human schistosomiasis: recent progress, new developments, and future prospects.;AJ Molehin;Int J Mol Sci.,2022
3. Schistosomiasis control: praziquantel forever?;D Cioli;Mol Biochem Parasitol,2014
4. Spillover, hybridization, and persistence in schistosome transmission dynamics at the human-animal interface;A Borlase;Proc Natl Acad Sci USA,2011
5. Hybridizations within the genus Schistosoma: implications for evolution, epidemiology and control;E Léger;Parasitology,2017